Advertisement
Screener

MIRATI THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value

MIRATI THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value

MIRATI THERAPEUTICS, INC. had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $0 as of 2022-03-31, per its 10-Q filed 2022-05-04.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2022-05-04

  • 2022-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
  • 2021-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $8.22M.
  • 2020-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $15.63M.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
2022-03-31$0.00
10-Q · filed 2022-05-04
2021-12-31$8.22M
10-K · filed 2022-02-28
2020-12-31$15.63M
10-K · filed 2022-02-28